Abemaciclib: A Key Material in the Fight Against Hormone Receptor-Positive Breast Cancer
Abemaciclib is a type of cancer growth blocker that targets the proteins cyclin dependant kinase 4 and 6 (CDK4 and CDK6) on breast cancer cells. CDK 4 and CDK 6…